MAB002, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0101B)." alt="Human peripheral blood monocytes were stained with Human LILRA2/CD85h/ILT1 Monoclonal Antibody (Catalog # MAB6364, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0101B)." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB6364A | |||
| Carrier Free | MAB6364-SP | |||
| Carrier Free | FAB6364V-100UG | |||
| Carrier Free | FAB6364U-100UG | |||
| Carrier Free | FAB6364T-100UG | |||
| Carrier Free | FAB6364S-100UG | |||
| Carrier Free | FAB6364R-100UG | |||
| Carrier Free | FAB6364N-100UG | |||
| Carrier Free | FAB6364G-100UG | |||
HAF018). A specific band was detected for LILRA2/CD85h/ILT1 at approximately 69 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." alt="Western blot shows lysates of human peripheral blood mononuclear cells (PBMC). PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human LILRA2/CD85h/ILT1 Monoclonal Antibody (Catalog # MAB63641) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for LILRA2/CD85h/ILT1 at approximately 69 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." class="big_thumb" />
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB63641-SP | |||
![Western Blot: LILRA2 Overexpression Lysate (Adult Normal) [NBP2-07570] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for LILRA2.](http://images.novusbio.com/fullsize/LILRA2-Overexpression-Lysate-Adult-Normal-Western-Blot-NBP2-07570-img0001.jpg "Western Blot: LILRA2 Overexpression Lysate (Adult Normal) [NBP2-07570] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for LILRA2.")
![Western Blot: ILT1/CD85h/LILRA2 Antibody (3C7) [H00011027-M17] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 monoclonal antibody (M17), clone 3C7. Lane 1: LILRA2 transfected lysate (Predicted MW: 51.2 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/ILT1-CD85h-LILRA2-Antibody-3C7-Western-Blot-H00011027-M17-img0001.jpg "Western Blot: ILT1/CD85h/LILRA2 Antibody (3C7) [H00011027-M17] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 monoclonal antibody (M17), clone 3C7. Lane 1: LILRA2 transfected lysate (Predicted MW: 51.2 KDa). Lane 2: Non-transfected lysate.")
![Western Blot: ILT1/CD85h/LILRA2 Antibody (4D7) [H00011027-M14] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 monoclonal antibody (M14), clone 4D7. Lane 1: LILRA2 transfected lysate (Predicted MW: 51.2 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/ILT1-CD85h-LILRA2-Antibody-4D7-Western-Blot-H00011027-M14-img0001.jpg "Western Blot: ILT1/CD85h/LILRA2 Antibody (4D7) [H00011027-M14] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 monoclonal antibody (M14), clone 4D7. Lane 1: LILRA2 transfected lysate (Predicted MW: 51.2 KDa). Lane 2: Non-transfected lysate.")
![Western Blot: ILT1/CD85h/LILRA2 Antibody [H00011027-B01P] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 polyclonal antibody. Lane 1: LILRA2 transfected lysate(51.26 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/ILT1-CD85h-LILRA2-Antibody-Western-Blot-H00011027-B01P-img0002.jpg "Western Blot: ILT1/CD85h/LILRA2 Antibody [H00011027-B01P] - Analysis of LILRA2 expression in transfected 293T cell line by LILRA2 polyclonal antibody. Lane 1: LILRA2 transfected lysate(51.26 KDa). Lane 2: Non-transfected lysate.")
